...
首页> 外文期刊>Clinical breast cancer >The Role of Phosphoinositide 3-Kinase in Breast Cancer: An Overview
【24h】

The Role of Phosphoinositide 3-Kinase in Breast Cancer: An Overview

机译:磷酸肌醇3-激酶在乳腺癌中的作用:概述

获取原文
获取原文并翻译 | 示例

摘要

The family of lipid kinases termed phosphoinositide 3-kinases (PI3Ks), discovered in the 1980s, have been determined to have key roles in several cellular processes critical for tumorigenesis and tumor maintenance, including metabolism, growth, survival, and motil-ity. Inappropriate co-option of PI3K signaling is one of the most frequent occurrences found in human malignancies. As a result of its pivotal role in cancer, this pathway has been a major focus of cancer drug development. Despite many therapeutic agents already developed and under clinical investigation, it still remains unclear how best to define tumors most likely to benefit from these select drug therapies, what PI3K family members will be the most relevant to target for maximal therapeutic benefit, and whether certain members will be more appropriate for specific tumors. Simply stated, the PI3K family of related intracellular signal transducer enzymes phosphorylate the 3'-OH group on phospha-tidylinositols in the plasma membrane that subsequently leads to recruitment of the protein Ser/Thr-kinase, Akt, to the cell membrane. It is there that Atk becomes activated. The central component is the heterodimer phosphatidylinositol 3-kinase. This heterodimer is composed of 2 subunits: the regulatory p85 subunit and the catalytic p110 subunit. This PI3K-Akt signaling cascade is activated via several different mechanisms. It can either be activated directly by the GTPase protein Ras, or following membrane growth factor receptor tyrosine kinase activation. When activated, the inhibitory effect of the p85 is released, allowing for activation of the p110 catalytic subunit, which in turn converts membrane-related phosphatidylinositol-3,5 bisphosphonate (PIP2) to its tri-phosphate (PIP3) form. PIP3 is responsible for Akt phos-phorylation and it is this phosphorylation that results in many of the cell mediators of the PI3K pathway. Activation of this pathway has many downstream effects, including eventual alterati...
机译:在1980年代发现的被称为磷酸肌醇3激酶(PI3Ks)的脂质激酶家族已被确定在几个对肿瘤发生和肿瘤维持至关重要的细胞过程中具有关键作用,包括代谢,生长,存活和运动能力。 PI3K信号传递的不适当选择是人类恶性肿瘤中最常见的事件之一。由于其在癌症中的关键作用,该途径一直是癌症药物开发的主要重点。尽管已经开发出许多治疗剂并正在临床研究中,但仍不清楚如何最好地定义最有可能从这些选择的药物治疗中受益的肿瘤,PI3K家族的哪些成员将与最大的治疗获益最相关,以及某些成员是否将更适合于特定的肿瘤。简而言之,相关细胞内信号转导酶的PI3K家族磷酸化了质膜中磷脂酰酪氨酸肌醇上的3'-OH基团,随后导致蛋白Ser / Thr激酶Akt募集到细胞膜上。 Atk在那里被激活。中心成分是异二聚体磷脂酰肌醇3-激酶。该异二聚体由2个亚基组成:调节性p85亚基和催化性p110亚基。 PI3K-Akt信号级联反应是通过几种不同的机制激活的。它既可以被GTPase蛋白Ras直接激活,也可以被膜生长因子受体酪氨酸激酶激活后被激活。激活后,将释放p85的抑制作用,从而激活p110催化亚基,从而将膜相关的磷脂酰肌醇-3,5-双膦酸酯(PIP2)转变为其三磷酸(PIP3)形式。 PIP3负责Akt的磷酸化作用,正是这种磷酸化作用导致了PI3K途径的许多细胞介体。该途径的激活具有许多下游影响,包括最终的替代...

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号